Subtitle:

The pharmaceutical industry, innovation, generics and competitiveness in the context of EU Enlargement

Publisher:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Abstract:

The market of medicines in new members of European Union with population of 75 million people totaled in € 7 billions. The product patents were implemented during 1990’s in these countries. Patent protection is a key concern for research - based industry in unified market. In central and Eastern European markets the generics make about 70% of all medicines prescribed. The novelty on the market are “authorized generics”.

Relation:

Biotechnologia, vol.76, 1 (2007)-.

Volume:

76

Issue:

1

Start page:

176

End page:

185

Detailed Resource Type:

Article

Format:

application/pdf

Resource Identifier:

0860-7796 ; oai:rcin.org.pl:87166 ; IChB B-72

Source:

Library of Institute of Bioorganic Chemistry PAS

Language:

pol

Language of abstract:

eng

Temporal coverage:

1988-2010

Rights:

Creative Commons Attribution BY-SA 4.0 license

Terms of use:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitizing institution:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Original in:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Projects co-financed by:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Access:

Open